ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

4 Effective Ways to Overcome Mental Health Issues for Entrepreneurs

Mental health issues can turn your life upside down. These four tips will help you manage those negative feeling and learn to overcome those over time.

FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression